BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17387298)

  • 1. Human T-cell leukemia virus type I induces adult T-cell leukemia: from clinical aspects to molecular mechanisms.
    Yasunaga J; Matsuoka M
    Cancer Control; 2007 Apr; 14(2):133-40. PubMed ID: 17387298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HTLV-I and leukemogenesis].
    Yasunaga J; Matsuoka M
    Uirusu; 2006 Dec; 56(2):241-9. PubMed ID: 17446673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult T-cell leukemia-lymphoma as a viral disease: Subtypes based on viral aspects.
    Nosaka K; Matsuoka M
    Cancer Sci; 2021 May; 112(5):1688-1694. PubMed ID: 33630351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells.
    Satou Y; Yasunaga J; Yoshida M; Matsuoka M
    Proc Natl Acad Sci U S A; 2006 Jan; 103(3):720-5. PubMed ID: 16407133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human T-cell leukemia virus type 1 Tax oncoprotein represses the expression of the BCL11B tumor suppressor in T-cells.
    Takachi T; Takahashi M; Takahashi-Yoshita M; Higuchi M; Obata M; Mishima Y; Okuda S; Tanaka Y; Matsuoka M; Saitoh A; Green PL; Fujii M
    Cancer Sci; 2015 Apr; 106(4):461-5. PubMed ID: 25613934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The state of the art in the pathogenesis of ATL and new potential targets associated with HTLV-1 and ATL.
    Murata K; Yamada Y
    Int Rev Immunol; 2007; 26(5-6):249-68. PubMed ID: 18027200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanism of oncogenesis by human T-cell leukemia virus type 1].
    Matsuoka M
    Gan To Kagaku Ryoho; 2010 Jan; 37(1):10-3. PubMed ID: 20087027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching and loss of cellular cytokine producing capacity characterize in vivo viral infection and malignant transformation in human T- lymphotropic virus type 1 infection.
    Kagdi H; Demontis MA; Ramos JC; Taylor GP
    PLoS Pathog; 2018 Feb; 14(2):e1006861. PubMed ID: 29444188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adult T-cell leukemia induced by HTLV-1: before and after HBZ].
    Duc Dodon M; Mesnard JM; Barbeau B
    Med Sci (Paris); 2010 Apr; 26(4):391-6. PubMed ID: 20412744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-1 Tax and adult T-cell leukemia.
    Giam CZ; Jeang KT
    Front Biosci; 2007 Jan; 12():1496-507. PubMed ID: 17127397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cells of adult T-cell leukemia evade HTLV-1 Tax/NF-κB hyperactivation-induced senescence.
    Shudofsky AMD; Giam CZ
    Blood Adv; 2019 Feb; 3(4):564-569. PubMed ID: 30787019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HTLV-1 bZIP factor-specific CD4 T cell responses in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation.
    Narita T; Ishida T; Masaki A; Suzuki S; Ito A; Mori F; Yamada T; Ri M; Kusumoto S; Komatsu H; Miyazaki Y; Takatsuka Y; Utsunomiya A; Niimi A; Iida S; Ueda R
    J Immunol; 2014 Feb; 192(3):940-7. PubMed ID: 24363428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms of HTLV-1 infection and pathogenesis.
    Yasunaga J; Matsuoka M
    Int J Hematol; 2011 Nov; 94(5):435-42. PubMed ID: 21953273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-Cell Leukemia Virus Type 1 Infection and Adult T-Cell Leukemia.
    Chan CP; Kok KH; Jin DY
    Adv Exp Med Biol; 2017; 1018():147-166. PubMed ID: 29052136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
    Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
    Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New treatment strategy for adult T-cell leukemia targeting for anti-tumor immunity and a longevity gene-encoded protein].
    Kozako T
    Yakugaku Zasshi; 2011; 131(7):1061-72. PubMed ID: 21720136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor immunity against adult T-cell leukemia.
    Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
    Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HTLV-1: Recent topics in epidemiologic, basic and clinical research].
    Yasunaga J; Matsuoka M
    Uirusu; 2013; 63(2):165-74. PubMed ID: 25366051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.